{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T04:56:02Z","timestamp":1763441762815,"version":"3.45.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s10620-025-09134-4","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T13:55:10Z","timestamp":1750773310000},"page":"3653-3657","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Triple Threat: The Importance of Diagnosing \u201cTriple-Negative\u201d Primary Biliary Cholangitis"],"prefix":"10.1007","volume":"70","author":[{"given":"Cyril","family":"Mazhuvanchery","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shreeya","family":"Indulkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Triadafilopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao Chi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,24]]},"reference":[{"key":"9134_CR1","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1056\/NEJM199611213352107","volume":"335","author":"MM Kaplan","year":"1996","unstructured":"Kaplan MM. Primary biliary cirrhosis. N Engl J Med 1996;335:1570\u20131580.","journal-title":"N Engl J Med"},{"key":"9134_CR2","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/hep.510370134","volume":"37","author":"A Reuben","year":"2003","unstructured":"Reuben A. The serology of the Addison-Gull syndrome. Hepatology 2003;37:225\u2013228.","journal-title":"Hepatology"},{"key":"9134_CR3","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.cld.2018.03.009","volume":"22","author":"DM Chascsa","year":"2018","unstructured":"Chascsa DM, Lindor KD. Antimitochondrial antibody-negative primary biliary cholangitis: is it really the same disease? Clin Liver Dis 2018;22:589\u2013601.","journal-title":"Clin Liver Dis"},{"key":"9134_CR4","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000179","volume":"7","author":"J Trivella","year":"2023","unstructured":"Trivella J, John BV, Levy C. Primary biliary cholangitis: epidemiology, prognosis, and treatment. Hepatol Commun 2023;7:e0179.","journal-title":"Hepatol Commun"},{"key":"9134_CR5","doi-asserted-by":"publisher","first-page":"926","DOI":"10.4254\/wjh.v7.i7.926","volume":"7","author":"T Purohit","year":"2015","unstructured":"Purohit T, Cappell MS. Primary biliary cirrhosis: pathophysiology, clinical presentation and therapy. World J Hepatol 2015;7:926\u2013941.","journal-title":"World J Hepatol"},{"key":"9134_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.bpg.2018.06.007","volume":"34\u201335","author":"A Khanna","year":"2018","unstructured":"Khanna A, Leighton J, Wong LL, Jones DE. Symptoms of PBC\u2014pathophysiology and management. Best Pract Res Clin Gastroenterol 2018;34\u201335:41\u201347.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"9134_CR7","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1055\/s-0034-1383726","volume":"34","author":"BD Juran","year":"2014","unstructured":"Juran BD, Lazaridis KN. Environmental factors in primary biliary cirrhosis. Semin Liver Dis 2014;34:265\u2013272.","journal-title":"Semin Liver Dis"},{"key":"9134_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111754","volume":"140","author":"H Li","year":"2021","unstructured":"Li H, Guan Y, Han C, Zhang Y, Wei W, Ma Y. The pathogenesis, models and therapeutic advances of primary biliary cholangitis. Biomed Pharmacother 2021;140:111754.","journal-title":"Biomed Pharmacother"},{"key":"9134_CR9","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1053\/j.gastro.2004.05.005","volume":"127","author":"C Selmi","year":"2004","unstructured":"Selmi C, Mayo MJ, Bach N, Ishibashi H, Invernizzi P, Gish RG, Gordon SC, Wright HI, Zweiban B, Podda M, Gershwin ME. Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology 2004;127:485\u2013492.","journal-title":"Gastroenterology"},{"key":"9134_CR10","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/hep.21696","volume":"46","author":"M Miozzo","year":"2007","unstructured":"Miozzo M, Selmi C, Gentilin B, Grati FR, Sirchia S, Oertelt S, Zuin M, Gershwin ME, Podda M, Invernizzi P. Preferential X chromosome loss but random inactivation characterize primary biliary cirrhosis. Hepatology 2007;46:456\u2013462.","journal-title":"Hepatology"},{"key":"9134_CR11","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S0140-6736(04)15541-4","volume":"363","author":"P Invernizzi","year":"2004","unstructured":"Invernizzi P, Miozzo M, Battezzati PM, Bianchi I, Grati FR, Simoni G, Selmi C, Watnik M, Gershwi ME, Podda M. Frequency of monosomy X in women with primary biliary cirrhosis. Lancet 2004;363:533\u2013535.","journal-title":"Lancet"},{"key":"9134_CR12","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/hep.30145","volume":"69","author":"KD Lindor","year":"2019","unstructured":"Lindor KD, Bowlus CL, Boyer J, Levy C, Mayo M. Primary biliary cholangitis: 2018 practice guidance from the American Association for the Study of Liver Diseases. Hepatology 2019;69:394\u2013419.","journal-title":"Hepatology"},{"key":"9134_CR13","doi-asserted-by":"publisher","first-page":"25906","DOI":"10.1038\/srep25906","volume":"6","author":"A Lleo","year":"2016","unstructured":"Lleo A, Jepsen P, Morenghi E, Carbone M, Moroni L, Battezzati PM, Podda M, Mackay IR, Gershwin ME, Invernizzi P. Evolving trends in female to male incidence and male mortality of primary biliary cholangitis. Sci Rep 2016;6:25906.","journal-title":"Sci Rep"},{"key":"9134_CR14","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.cld.2022.06.008","volume":"26","author":"M Shaker","year":"2022","unstructured":"Shaker M, Mansour N, John BV. Primary biliary cholangitis in males: pathogenesis, clinical presentation, and prognosis. Clin Liver Dis 2022;26:643\u2013655.","journal-title":"Clin Liver Dis"},{"key":"9134_CR15","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1155\/2010\/546926","volume":"29","author":"D Smyk","year":"2010","unstructured":"Smyk D, Mytilinaiou MG, Rigopoulou EI, Bogdanos DP. PBC triggers in water reservoirs, coal mining areas and waste disposal sites: from Newcastle to New York. Dis Markers 2010;29:337\u2013344.","journal-title":"Dis Markers"},{"key":"9134_CR16","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1093\/qjmed\/hcm059","volume":"100","author":"P Muratori","year":"2007","unstructured":"Muratori P, Granito A, Papps G, Muratori L, Quarneti C, De Molo C, Cipriano V, Vukotic R, Andreone P, Lenzi M, Bianchi FB. Clinical and serological profile of primary biliary cirrhosis in men. QJM 2007;100:534\u2013535.","journal-title":"QJM"},{"key":"9134_CR17","doi-asserted-by":"publisher","first-page":"S1543","DOI":"10.14309\/01.ajg.0000600704.10755.67","volume":"114","author":"K Zakharia","year":"2019","unstructured":"Zakharia K, Julian R, Rasor M, He X, Altamimi BA, Murali A, Sanchez AJ. Primary biliary cholangitis (PBC): any differences between males and females? Am J Gastroenterol 2019;114:S1543.","journal-title":"Am J Gastroenterol"},{"key":"9134_CR18","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1007\/s10620-020-06498-7","volume":"66","author":"Y Natarajan","year":"2021","unstructured":"Natarajan Y, Tansel A, Patel P, Emologu K, Shukla R, Qureshi Z, El-Serag HB, Thrift AP, Kanwl F. Incidence of hepatocellular carcinoma in primary biliary cholangitis: a systematic review and meta-analysis. Dig Dis Sci 2021;66:2439\u20132451. https:\/\/doi.org\/10.1007\/s10620-020-06498-7.","journal-title":"Dig Dis Sci"},{"key":"9134_CR19","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.1478-3231.1999.tb00020.x","volume":"19","author":"P Angulo","year":"1999","unstructured":"Angulo P, Lindor KD, Therneau TM, Jorgensen RA, Malinchoc M, Kamath PS, Dickson ER. Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid. Liver 1999;19:115\u2013121.","journal-title":"Liver"},{"key":"9134_CR20","doi-asserted-by":"publisher","first-page":"745","DOI":"10.3109\/00365521.2015.1132337","volume":"51","author":"G Juliusson","year":"2016","unstructured":"Juliusson G, Imam M, Bjornsson ES, Talwalkar JA, Lindor KD. Long-term outcomes in antimitochondrial antibody negative primary biliary cirrhosis. Scand J Gastroenterol 2016;51:745\u2013752.","journal-title":"Scand J Gastroenterol"},{"key":"9134_CR21","first-page":"1440","volume":"22","author":"K Tsuneyama","year":"1995","unstructured":"Tsuneyama K, Van De Water J, Van Thiel D, Coppel R, Ruebner B, Nakanuma Y, Dickson ER, Gershwin ME. Abnormal expression of PDC-E2 on the apical surface of biliary epithelial cells in patients with antimitochondrial antibody-negative primary biliary cirrhosis. Hepatology 1995;22:1440\u20131446.","journal-title":"Hepatology"},{"key":"9134_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1046\/j.1365-2036.2003.01381.x","volume":"17","author":"JP Gisbert","year":"2003","unstructured":"Gisbert JP, Jones EA, Pajares JM, Moreno-Otero R. Review article: is there an optimal therapeutic regimen for antimitochondrial antibody-negative primary biliary cirrhosis (autoimmune cholangitis)? Aliment Pharmacol Ther 2003;17:17\u201327.","journal-title":"Aliment Pharmacol Ther"},{"key":"9134_CR23","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/liv.15079","volume":"42","author":"BV John","year":"2022","unstructured":"John BV, Dahman B, Deng Y, Khakoo NS, Taddei TH, Kaplan DE, Levy C. Rates of decompensation, hepatocellular carcinoma and mortality in AMA-negative primary biliary cholangitis cirrhosis. Liver Int 2022;42:384\u2013393.","journal-title":"Liver Int"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09134-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-025-09134-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09134-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T04:53:39Z","timestamp":1763441619000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-025-09134-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,24]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["9134"],"URL":"https:\/\/doi.org\/10.1007\/s10620-025-09134-4","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"type":"print","value":"0163-2116"},{"type":"electronic","value":"1573-2568"}],"subject":[],"published":{"date-parts":[[2025,6,24]]},"assertion":[{"value":"11 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent for this case report was obtained from the patient. Patient name and identifying information have been removed from all figures.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}